# Collection of Anti-SARS-CoV-2 Immune Plasma

> **NCT04344977** · — · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 151 (actual)

## Conditions studied

- Coronavirus Disease 2019 (COVID-19)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04344977
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-01
- **Primary completion:** 2020-11-20
- **Final completion:** 2021-03-03
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2021-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04344977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04344977, "Collection of Anti-SARS-CoV-2 Immune Plasma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04344977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*